Biocept, Inc.
BIOC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $3 | $18 | $18 | $2 |
| - Cash | $13 | $29 | $14 | $9 |
| + Debt | $12 | $13 | $12 | $3 |
| Enterprise Value | $2 | $2 | $15 | -$5 |
| Revenue | $26 | $61 | $27 | $6 |
| % Growth | -57.8% | 123% | 396.7% | – |
| Gross Profit | -$3 | $23 | $6 | -$5 |
| % Margin | -10% | 38.3% | 22.3% | -98.6% |
| EBITDA | -$30 | -$2 | -$14 | -$23 |
| % Margin | -117.3% | -3.9% | -52.7% | -417.1% |
| Net Income | -$32 | -$3 | -$17 | -$25 |
| % Margin | -124.1% | -4.6% | -62.1% | -445.2% |
| EPS Diluted | -56.78 | -5.73 | -43.16 | -357.41 |
| % Growth | -890.9% | 86.7% | 87.9% | – |
| Operating Cash Flow | -$13 | $4 | -$20 | -$23 |
| Capital Expenditures | -$1 | -$2 | -$1 | -$1 |
| Free Cash Flow | -$14 | $2 | -$21 | -$24 |